Refractory status epilepticus.
No Thumbnail Available
Date
2006-12-23
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Refractory status epilepticus (RSE) is a common problem in intensive care units and emergency departments. The important risk factor predisposing patients with SE to RSE is delay in receiving treatment. Self-sustaining SE is associated with progressive, time-dependent development of pharmacoresistance. Early termination of convulsive SE by aggressive treatment is the best way to prevent RSE. RSE once develop, requires more aggressive treatment as it is associated with higher mortality and morbidity. To date, no randomized controlled trials have been done for RSE. The most experience exists with coma inducing agents like pentobarbital, midazolam and propofol. New evidence suggests for the possible role of newer AEDs.
Description
73 references.
Keywords
Citation
Murthy JM. Refractory status epilepticus. Neurology India. 2006 Dec; 54(4): 354-8